Skip to search formSkip to main contentSkip to account menu

PD 184352

Known as: PD 184352/CI-1040, PD-184352, MEK Inhibitor CI-1040 
An agent that inhibits both mitogen-activated protein kinase kinases 1 and 2 (MEK1 and MEK2), substrates of Raf and phosphorylates extracellular… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Mitogen-activated protein kinases (MAPKs) play important roles in various cellular functions including proliferation… 
2016
2016
In Fig. 3A, the image of mouse hepatocytes overexpressing p21 and treated with PD184352 (PD) and deoxycholic acid (DCA) was… 
2016
2016
It has been pointed out to us that the control 0 min time point bands in Figure 2E were duplicated. The control lanes were… 
2014
2014
Hepatocyte tumor cell lines lack the expression or induction properties of major cytochrome P450 (CYP) enzymes compared to… 
2012
2012
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Mcl-1, a critical survival factor for human… 
2009
2009
The MEK5/ERK5 pathway has recently been implicated in prostate and breast carcinogenesis. Over-expression of MEK5 is associat ed… 
2007
2007
Chronic exposure to lower oxygen tension may increase cellular resistance to different types of acute metabolic stress. Here, we… 
2007
2007
Objective:To observe the influence of PD184352 on the proliferation and expression of ERK protein of squamous cell carcinoma… 
2002
2002
The effects of combined exposure to the checkpoint abrogator UCN-01 and pharmacologic MEK1/2 inhibitors were examined in human… 
2001
2001
Antibodies that recognise the active phosphorylated forms of mitogen-activated protein kinase (MAPK) kinase 5 (MKK5) and…